Immunome, Inc. (IMNM)
19.49
-0.81
(-3.99%)
USD |
NASDAQ |
Dec 11, 16:00
19.47
-0.02
(-0.10%)
After-Hours: 20:00
Immunome EPS Diluted (Quarterly): -0.6532 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Precision BioSciences, Inc. | -1.842 |
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -57.46M |
| Total Expenses (Quarterly) | 57.46M |
| Enterprise Value | 1.519B |
| Earnings Yield | -15.17% |
| Normalized Earnings Yield | -13.60 |